Using Disease Management and Market Reforms to Address the Adverse Economic Effects of Drug Budgets and Price and Reimbursement Regulations in GermanyTim Schwermann, J.‐Matthias Graf v. d. Schulenburg, Wolfgang Greiner|Value in Health|2003Cited by 21